Merck Non-GAAP EPS of $1.85 beats by $0.14, revenue of $15B beats by $950M, raises FY22 outlook

Oct. 27, 2022 6:31 AM ETMerck & Co., Inc. (MRK)By: Gaurav Batavia, SA News Editor4 Comments
  • Merck press release (NYSE:MRK): Q3 Non-GAAP EPS of $1.85 beats by $0.14.
  • Revenue of $15B (+14.1% Y/Y) beats by $950M.
  • LAGEVRIO Sales Were $436 Million; Growth Excluding LAGEVRIO Was 10%; Growth Excluding LAGEVRIO and the Impact From Foreign Exchange Was 14%; Sales Growth Favorably

Recommended For You

Comments (4)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.